Search

everythinglearnresearchcommunity

for

Search:↓

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

New progesterone-based compounds can block male hormones.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

PT-20 did not significantly improve gray hair repigmentation.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

The PP2A-B55α protein is essential for brain and skin development in embryos.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Clascoterone may be an effective topical treatment for hair loss.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

The microneedle patch boosts hair growth by reducing DHT and oxidative stress.

Finasteride helps reduce heart issues and improves heart function.

Potential new drugs for treating PCOS were identified.

p2y5, now called LPA6, is a receptor important for human hair growth.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Apremilast may help treat hair loss in alopecia areata.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

Individualized treatments may help manage Dercum's disease symptoms.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.